Guardant Health (GH) Other Accumulated Expenses (2023 - 2024)

Guardant Health (GH) posted Other Accumulated Expenses of $68.3 million for Q4 2024, up 7.67% sequentially from $63.5 million in Q4 2023, and up 7.67% YoY from $63.5 million in Q1 2024.

Guardant Health (GH) Other Accumulated Expenses (2023 - 2024) Analysis & Trends

Guardant Health (GH) has 2 years of Other Accumulated Expenses data on file, last reported at $68.3 million in Q4 2024.

  • Quarterly Other Accumulated Expenses rose 7.67% year-over-year to $68.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $68.3 million (up 7.67% YoY) and the FY2024 annual result came in at $68.3 million, up 7.67% from the prior year.
  • Other Accumulated Expenses advanced to $68.3 million in Q4 2024 per GH's latest filing, from $63.5 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $68.3 million in Q4 2024, with the low at $63.5 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Guardant Health 22.42 Bn 21.31 Bn 196.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 68.35 Mn
Dec 31, 2023 63.48 Mn